drugset / Trial / NCT04289532
Integrin α6-targeted SPECT Imaging of Breast Cancer
Phase 0
Completed
9 enrolled
Peking University
China-Japan Union Hospital, Jilin University · collabSun Yat-sen University · collab
NaSingle-groupOpen-labelDiagnostic
Summary
A novel radiotracer 99mTc-RWY targeting Integrin α6 was developed, and the pilot first-in-human study for SPECT imaging of breast cancer was performed in seven healthy volunteers and two breast cancer patients to assess the safety and potential clinical applications of 99mTc-RWY.
Timeline
- Start
- 2018-03-08
- Primary completion
- 2019-06-01
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 99mTc-RWY | Unknown | 11.1 mbq/kg | Intravenous |